Aquestive Therapeutics Reports Positive Initial Topline
AQST-109 is the first and only orally delivered epinephrine product candidate in clinical developmentFastest median time to maximum concentration (Tmax) in...
Source: globenewswire.com
Stay updated with breaking news from Mean Cmax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AQST-109 is the first and only orally delivered epinephrine product candidate in clinical developmentFastest median time to maximum concentration (Tmax) in...